venlafaxine (Q898407)

venlafaxine (English)

3 October 2016

chemical formula

C₁₇H₂₇NO₂

1 reference

venlafaxine (English)

19 November 2016

canonical SMILES

CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O

1 reference

venlafaxine (English)

19 November 2016

melting point

216±1 degree Celsius

1 reference

https://de.wikipedia.org/?oldid=222760882

German Wikipedia

Wikimedia import URL

defined daily dose

0.1 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N06AX16

1 reference

14 February 2018

World Health Organisation international non-proprietary name

venlafaxine (English)

1 reference

venlafaxine (English)

medical condition treated

3 October 2016

attention deficit hyperactivity disorder

1 reference

obsessive-compulsive disorder

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

2 references

13 December 2016

2 October 2018

2 references

13 December 2016

https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1592/phco.24.6.621.34748

chronic fatigue syndrome

1 reference

13 December 2016

1 reference

generalized anxiety disorder

13 December 2016

1 reference

2 October 2018

migraine

1 reference

2 October 2018

fibromyalgia

1 reference

post-traumatic stress disorder

2 October 2018

1 reference

2 October 2018

anxiety

1 reference

borderline personality disorder

2 October 2018

1 reference

significant drug interaction

2 October 2018

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

zolpidem

1 reference

Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction

saquinavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Ketoconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Solute carrier family 6 member 2

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

solute carrier family 6 member 4

17 August 2016

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

legal status (medicine)

prescription drug

applies to jurisdiction

Germany

0 references

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category B2

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

English Wikipedia

US pregnancy category C

1 reference

selective serotonin reuptake inhibitor

English Wikipedia

subject has role

1 reference

5 March 2018

adrenergic uptake inhibitors

1 reference

5 March 2018

serotonin–norepinephrine reuptake inhibitor

0 references

Commons category

Venlafaxine

0 references

Identifiers

Bibliothèque nationale de France ID

136028605

subject named as

Venlafaxine

1 reference

Nuovo soggettario

https://thes.bncf.firenze.sbn.it/termine.php?id=5871

13 June 2021

1 reference

National Library of Israel

Library of Congress authority ID

sh98003963

subject named as

Venlafaxine

1 reference

Nuovo soggettario

https://thes.bncf.firenze.sbn.it/termine.php?id=5871

InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3

13 June 2021

InChI

1 reference

venlafaxine (English)

19 November 2016

2 references

venlafaxine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

93413-69-5

2 references

venlafaxine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=93413-69-5

10 April 2021

1 reference

Venlafaxine (English)

19 November 2016

2 references

venlafaxine (English)

19 November 2016

Reaxys registry number

4234848

1 reference

venlafaxine (English)

3 October 2016

ChEBI ID

9943

mapping relation type

2 references

VENLAFAXINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3

1 reference

VENLAFAXINE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU150201

1 reference

MassBank accession ID

SM832201

0 references

0 references

MSBNK-Athens_Univ-AU150202

0 references

MSBNK-Athens_Univ-AU150203

0 references

MSBNK-Athens_Univ-AU150204

0 references

MSBNK-Athens_Univ-AU150205

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Eawag_Additional_Specs-ET190001

0 references

MSBNK-Eawag_Additional_Specs-ET190002

0 references

MSBNK-Eawag_Additional_Specs-ET190003

0 references

MSBNK-Eawag_Additional_Specs-ET190004

0 references

MSBNK-Eawag_Additional_Specs-ET190005

0 references

MSBNK-Env_Anal_Chem_U_Tuebingen-TUE00811

0 references

MSBNK-Env_Anal_Chem_U_Tuebingen-TUE00812

0 references

MSBNK-Env_Anal_Chem_U_Tuebingen-TUE00813

0 references

MSBNK-Waters-WA000318

0 references

MSBNK-Waters-WA000319

0 references

MSBNK-Waters-WA000320

0 references

MSBNK-Waters-WA000321

0 references

MSBNK-Waters-WA000322

0 references

SPLASH

splash10-004i-0090000000-182f1032c3f72220679d

0 references

splash10-00dj-0910000000-c7a4a25a9bc95faa6db1

0 references

splash10-00di-0900000000-7be3d65db3af35be404e

0 references

splash10-00di-0900000000-615322444dcf11a7fb8d

0 references

splash10-03di-0090000000-d212108d9a8267ed7dad

0 references

splash10-004i-0090000000-0c4e12d13e69311b26bf

0 references

splash10-0bvi-4090000000-8bf2805a95084bfd952a

0 references

splash10-0a4i-9520000000-de599153aa118f97ad81

0 references

splash10-0ab9-8900000000-6e9f54b654899b486e4d

0 references

splash10-0ab9-9800000000-d762b2d7edeba1e12b28

0 references

splash10-0ab9-9700000000-2b8ebcefcf1274550d32

0 references

splash10-004i-0090000000-c592b4ae2ead9b2bb7ea

0 references

splash10-0bvi-4090000000-30b9b5dca017215ebaa4

0 references

splash10-0a4i-9620000000-ab905f15470a13b750c5

0 references

splash10-0ab9-8900000000-52ec7a86d35dbbd47681

0 references

splash10-0ab9-9800000000-7a7cc5b11e1a30499063

0 references

splash10-0ab9-9700000000-062f05f9fe2a1540985c

0 references

splash10-03di-0090000000-8eb971c1dc9a14696c31

0 references

splash10-01t9-2090000000-af607e34f7f6700231a4

0 references

splash10-0a4i-9140000000-0b22aeda0f56bf825768

0 references

splash10-0a4i-9300000000-f28ae1a2451e218836c6

0 references

splash10-0a4i-9400000000-c36a2f70d6d9fd69dbfe

0 references

splash10-0a4i-9500000000-43a71bea54c5b09c4c9a

0 references

splash10-0a4i-9400000000-9763935e9812b45adddb

0 references

splash10-0bvi-6090000000-fabb5e8a0fd59b8420ca

0 references

splash10-0a4i-9100000000-b67e5a7dbbd83cf2a7a7

0 references

splash10-0a4i-9200000000-2300decf19900a1b84e4

0 references

splash10-03di-0090000000-b636993619fd34043527

0 references

splash10-0a4i-9260000000-0b8e3be9620e0271d683

0 references

splash10-01t9-2090000000-94fb4781a9910b6b1932

0 references

splash10-0a4i-9140000000-e2c800f5f39f048c545a

0 references

splash10-0a4i-9400000000-e0fa4c4197355be8d0fa

0 references

splash10-0a4i-9500000000-23cbb70f5d3c368966bb

0 references

splash10-0a4i-9500000000-998e2271dd7ac0572d54

0 references

HSDB ID

6699

1 reference

Hazardous Substances Data Bank

28 October 2019

Venlafaxine (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.122.418

27 December 2018

ECHA Substance Infocard ID

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol (English)

quotation

CAS no.: 93413-69-5 (English)

100.122.418

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.122.418

27 December 2018

1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol (English)

quotation

CAS no.: 93413-69-5 (English)

1 reference

Venlafaxine (English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

venlafaxine (English)

19 November 2016

1 reference

venlafaxine (English)

19 November 2016

DrugBank ID

DB00285

1 reference

Human Metabolome Database ID

HMDB0005016

2 references

based on heuristic

inferred from InChIKey

2 references

venlafaxine (English)

19 November 2016

MedlinePlus drug identifier

a694020

0 references

PatientsLikeMe treatment ID

0 references

1 reference

venlafaxine (English)

19 November 2016

0 references

1 reference

1 reference

venlafaxine (English)

3 October 2016

1 reference

Encyclopædia Britannica Online ID

venlafaxine (English)

3 October 2016

1 reference

topic/venlafaxine

subject named as

venlafaxine

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Römpp online ID

RD-22-00274

1 reference

1 reference

venlafaxine (English)